We recently published a list of Jim Cramer Breaks Silence On DeepSeek AI Sell-Off & Discusses These 12 Stocks. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) ...
Texas Gov. Greg Abbott, continuing a three-day series of border security-related actions, issued five executive orders Wednesday directing state agencies to assist President Donald Trump’s immigration ...
Gov. Greg Abbott ordered the Texas Department of Public Safety to deploy what he called “tactical strike teams” to assist President Donald Trump’s administration’s efforts to arrest ...
In a report released yesterday, David Toung from Argus Research maintained a Buy rating on Abbott Laboratories (ABT – Research Report). The ...
1d
The global point of care diagnostics market valued at US$ 14.26 billion in 2023, is forecasted to grow at a robust CAGR of 8.5%, reaching US$ ...
The global point of care diagnostics market valued at US$ 14.26 billion in 2023, is forecasted to grow at a robust CAGR of ...
BRG announced today that Rich Rieger has joined the firm's Health Analytics practice, where he will advise biopharmaceutical and MedTech companies on driving growth, performance improvement and ...
EXCLUSIVE: Baryshnikov Arts, the New York City multidisciplinary arts organization founded in 2005 by artistic director ...
The company reported revenue of $10.97 billion and earnings of $1.34 on a per-share and adjusted basis, compared to the consensus estimates of $11.01 billion and ...
In a report released today, Matt Miksic from Barclays maintained a Buy rating on Abbott Laboratories (ABT – Research Report), with a price ...
Financial analysis of Abbott Laboratories Q4 2024 results and 2025 outlook, with a 'Buy' rating due to revenue growth and EPS ...
Governor Greg Abbott this week officially demanding reimbursement for the $11 billion shelled out by Texas taxpayers to do a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback